Parasitic infection enables helpful bacteria to displace harmful ones in mice and humans
Infection with worms counters inflammatory bowel diseases (IBD) by triggering immune responses that change the mix of bacteria, or microbiome, in the gut. This is according to a study published online April 14 in the journal Science.
The study results support the hygiene hypothesis which, in the case of IBD, argues that the absence of exposure to worms in too-clean modern living spaces has left some with oversensitive, gut-based immune systems vulnerable to inflammatory diseases. Gut worms have helped to train and balance immune systems throughout human evolution, but are now missing in developed nations, which, in turn, have the highest rates of Crohn’s disease and ulcerative colitis.
In the newly published study, a team led by researchers from NYU Langone Medical Center found that mice infected with intestinal worms experienced as much as a thousand-fold decrease in Bacteroides — a group of bacterial species linked by past studies to higher risk for IBD. At the same time, the number of Clostridia, a bacterial species known to counter inflammation, increased tenfold. The investigators argue that the immune response to the worms triggers the growth in Clostridia, which then either outcompete Bacteroides for nutrients or release toxins harmful to Bacteroides.
“Our findings are among the first to link parasites and bacteria to the origin of IBD, supporting the hygiene hypothesis,” says study co-senior investigator and parasitologist P’ng Loke, PhD, an associate professor at NYU Langone. Loke says this model may also be applicable to other autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, and type 1 diabetes, in which processes meant to attack foreign invaders instead become oversensitive and react to the body’s own cells.
Also among the study’s key findings was that people in rural parts of Malaysia, a region known to have low rates of IBD but a high incidence of worm infections, had significantly more Clostridia and fewer Bacteriodes in their microbiomes than people comprising a nearby urban population. In addition, the researchers found that people treated and dewormed had less Clostridia and more Bacteriodes.
“Our study could change how scientists and physicians think about treating IBD,” says study co-senior investigator and microbiologist Ken Cadwell, PhD, an assistant professor at NYU Langone and its Skirball Institute of Biomolecular Medicine. “Patient testimonials and anecdotes lead many to think that worms directly cure IBD, while in reality, they act on the gut bacteria thought to cause the disease.”
Loke also led a study, published in the journal PLOS Pathogens in 2012, which found that giving worm eggs to monkeys protected them from the simian version of IBD. Worm eggs may be able to trick the immune system into thinking it has a worm infection, and to trigger a specific kind of worm-related response that counters gut inflammation. Along the same lines, future treatments might include giving patients some form of the immune chemicals produced by immune cells in the presence of worm infection, like interleukin 13, Cadwell says. Such treatments may be acceptable to patients as long as they know they cannot possibly get worms in the process.
As part of the new study, the NYU Langone team fed between 10 and 15 parasitic whipworm eggs to mice lacking a gene called NOD2, which is tied to several immune disorders, including IBD. After the worms matured, the investigators measured the amount of Bacteroides and Clostridia in the mice’s intestines and stool and noted the presence or absence of IBD. They found that many of the symptoms of IBD, such as intestinal bleeding and ulceration, went away along with almost all Bacteroides, while the Clostridia levels increased.
For another part of the study, the researchers compared the bacteria found in 75 members of the Orang Asli indigenous people in rural Malaysia to those of 20 people living in urban Kuala Lumpur. Researchers found that rural people had much fewer Bacteroides than city dwellers.
Cadwell says he and Loke plan to investigate how Clostridia outcompete Bacteroides, and search for harmless Clostridia species that can still induce this effect. In addition, they intend to explore alterations to gut bacteria by worm infections as the foundation of treatments for several inflammatory diseases.
The Latest on: Inflammatory Bowel Disease
via Google News
The Latest on: Inflammatory Bowel Disease
- What Caused Young IBD Patient's Headache and Right-Side Weakness? on April 15, 2019 at 11:38 am
Am J Case Rep 2019; 20: 419-422 2. DeFilippis EM, et al: Cerebral venous thrombosis in inflammatory bowel disease. J Dig Dis 2015; 16(2): 104–108 3. Algahtani FH, et al: Thromboembolic events in ... […]
- Crohn's disease research set to benefit from £1.8m funding boost on April 15, 2019 at 1:11 am
The £1.8 million award to the University of Edinburgh will help improve how experts monitor and determine outcomes for the inflammatory bowel disease (IBD) that affects some 120,000 people in the UK. ... […]
- Why Do I Have IBD? Treatment Options and Research in IBD on April 11, 2019 at 10:46 am
Mayo Clinic gastroenterologist William Faubion, M.D., discusses which treatment options, including active research, are available to pediatric patients with inflammatory bowel disease (IBD). This is ... […]
- HBV Revaccination Strategies Evaluated in IBD Patients After Initial Vaccination Failure on April 10, 2019 at 9:08 am
vaccine doses is recommended for inflammatory bowel disease (IBD) patients with initial HBV vaccination failure. In order to determine the effectiveness of revaccination strategies after initial HBV ... […]
- VIDEO: ‘Explosion’ of IBD therapies has gastroenterologists evaluating how to best sequence treatments on April 8, 2019 at 1:31 pm
Rubin, MD, section chief of Gastroenterology, Hepatology and Nutrition, and co-director of the Digestive Diseases Center at the University of Chicago Medicine, discusses some of the existing and ... […]
- ILC3 function as a double-edged sword in inflammatory bowel diseases on April 8, 2019 at 3:21 am
Group 3 innate lymphoid cells (ILC3) are responsible for gastrointestinal mucosal homeostasis through moderate generation of IL-22, IL-17 and GM-CSF in the physiological state. The dysregulation of ... […]
- Global $2.39 Bn Bowel Management Systems Markets, 2017 & 2018-2026 - Rising Prevalence of Inflammatory Bowel Disease and Fecal Incontinence Worldwide on April 8, 2019 at 2:30 am
Dublin, April 08, 2019 (GLOBE NEWSWIRE) -- The "Global Bowel Management Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... […]
- Challenges remain, but microbiome may hold guide to inflammatory disease on April 5, 2019 at 5:28 pm
CHICAGO — Inflammatory bowel disease is known as a prototype for new-age diseases. It grew out of industrializing countries a little more than a century ago and the prevalence grew as populations ... […]
- Cytomegalovirus reactivation in inflammatory bowel disease: an uncommon occurrence related to corticosteroid dependence on April 5, 2019 at 2:23 pm
Cytomegalovirus promotes mucosal injury in patients with inflammatory bowel disease, historically affecting 10–25% of ulcerative colitis patients with refractory disease. Viral reactivation is likely ... […]
- India- Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives on April 4, 2019 at 7:42 pm
(MENAFN - GetNews) This article by Dr. Prashanth Rawla, et al., is published in the Journal of Inflammation Research, Volume 11, 2018: 215-226. Inflammatory bowel disease (IBD) is a chronic ... […]
via Bing News